ACHV
Achieve Life Sciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$171.97M
P/E Ratio
—
EPS
$-1.25
Beta
1.96
52W High
$6.03
52W Low
$1.84
50-Day MA
$4.09
200-Day MA
$3.81
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
35.34
PEG Ratio
17.68
About Achieve Life Sciences Inc
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and markets cytisinicline for smoking and nicotine addiction cessation in the United States and internationally. The company is headquartered in Vancouver, Canada.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-54.65M |
| Operating Margin | 0.00% |
| Return on Equity | -257.70% |
| Return on Assets | -85.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.40 |
| Price-to-Book | 7.99 |
| Price-to-Sales (TTM) | 5.09 |
| EV/Revenue | 0.625 |
| EV/EBITDA | -2.42 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $53.24M |
| Float | $47.13M |
| % Insiders | 4.37% |
| % Institutions | 46.88% |
Analyst Ratings
Consensus ($14.75 target)
2
Strong Buy5
BuyData last updated: 4/7/2026